Delcath Systems, Inc. announced the appointment of Dr. Vojislav "Vojo" Vukovic as its new Chief Medical Officer. Dr. Vukovic is an experienced drug development executive with a distinguished career in cancer research and global clinical development. His experience spans early to late-stage oncology clinical projects and global medical affairs programs across multiple anti-cancer modalities and tumor types.

He has held the position of Senior Vice President and Chief Medical Officer at Aileron Therapeutics, Taiho Oncology Inc., and Synta Pharmaceuticals Inc. overseeing various facets of clinical development, medical affairs and corporate strategy. Dr. Vukovic earned his MD from the University of Sarajevo, a MSc in Radiation Biology and a PhD in Tumor Biology from the University of Toronto. His work has been published in several high-impact scientific journals, and he is a member of the American Association for Cancer Research, the American Society of Clinical Oncology, the American Society of Hematology, and the European Society for Medical Oncology.